18F-FSPG PET/MRI or PET/CT Imaging of Cardiac Sarcoidosis or Inflammation



Status:Recruiting
Healthy:No
Age Range:18 - Any
Updated:2/17/2019
Start Date:August 2, 2017
End Date:April 2021
Contact:Andrea Otte, DPT
Email:anotte@stanford.edu
Phone:(650) 736-4183

Use our guide to learn which trials are right for you!

The investigators will evaluate the detection of cardiac sarcoidosis or inflammation using
18F-FSPG PET/MRI.

PET/MRI scans will be performed with a whole-body PET/MR imaging system capable of
simultaneous PET and MR imaging (SIGNA, GE Healthcare, Milwaukee, WI). Approximately 45-60
minutes after IV injection of 8 mCi of 18F-FSPG, PET emission scanning and MRI acquisition T1
weighted scanning will begin imaging both whole body and the heart.

Inclusion Criteria:

- Patient is ≥ 18 years old at the time of the scan

- Patient with known or suspected cardiac sarcoidosis.

- Patient is capable of complying with study procedures

- Patient can remain still for duration of imaging procedure

Exclusion Criteria:

- Patient is pregnant or nursing

- Metallic implants (contraindicated for MRI)

- History of renal insufficiency (only for MRI contrast administration)
We found this trial at
1
site
450 Serra Mall
Stanford, California 94305
(650) 723-2300
Phone: 650-736-4183
Stanford University Stanford University, located between San Francisco and San Jose in the heart of...
?
mi
from
Stanford, CA
Click here to add this to my saved trials